Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2026 Filed Oct 7, 2026 00:53 UTC |
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
|
SaleOrdinary Shares | 27,659 | $10.64 | $294,291.76 |
DisclosureSEC source: 0001742771-26-000014 · form4-10072026_121015.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF SCI OFCR, OPHTHALMOLOGY 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 613,187 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.53 to $10.88, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 23, 2026 Filed Sep 25, 2026 01:05 UTC |
SEBULSKY ALANDirector
|
GrantRestricted Share Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001092348-26-000006 · form4-09252026_010933.xml · derivative · entry 1 SEBULSKY ALAN · CIK 0001092348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: One-third of the restricted share unit award will vest on each of the first, second, and third anniversaries of the grant date. F2 · derivative.expiration_date: One-third of the restricted share unit award will vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 01:03 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
SaleOrdinary Shares | 62,000 | $13.86 | $859,320.00 |
DisclosureSEC source: 0001678604-26-000020 · form4-08192026_010821.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,325,695 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $13.59 to $14.00, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2026 Filed Jul 22, 2026 01:12 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 56,000 | $12.51 | $700,560.00 |
DisclosureSEC source: 0001742734-26-000018 · form4-07222026_010715.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 908,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.63, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 07, 2026 Filed Jul 8, 2026 01:05 UTC |
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
|
SaleOrdinary Shares | 25,112 | $14.90 | $374,168.80 |
DisclosureSEC source: 0001742771-26-000012 · form4-07072026_090701.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · CHIEF SCI OFCR, OPHTHALMOLOGY 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 640,846 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $14.47 to $15.33, inclusive. Read SEC document |
| July 07, 2026 Filed Jul 8, 2026 01:05 UTC |
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
|
SaleOrdinary Shares | 2,547 | $13.86 | $35,301.42 |
DisclosureSEC source: 0001742771-26-000012 · form4-07072026_090701.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF SCI OFCR, OPHTHALMOLOGY 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 665,958 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $13.36 to $14.31, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:18 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
GrantRestricted Share Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001815161-26-000008 · form4-06302026_010631.xml · derivative · entry 1 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:19 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
GrantRestricted Share Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001745347-26-000010 · form4-06302026_010612.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:17 UTC |
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
|
GrantRestricted Share Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001742771-26-000010 · form4-06302026_010642.xml · derivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF SCI OFCR, OPHTHALMOLOGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:17 UTC |
Giroux RichardCFO & COO
|
GrantRestricted Share Units · Derivative | 980,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001742734-26-000014 · form4-06302026_010607.xml · derivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 980,000 Underlying: Ordinary Shares · 980,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:16 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
GrantRestricted Share Units · Derivative | 980,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001678604-26-000016 · form4-06302026_010639.xml · derivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 980,000 Underlying: Ordinary Shares · 980,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
GrantRestricted Share Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-271152 · ownership.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share of the Issuer upon settlement. The restricted share units become settleable when Ellen Hukkelhoven ("Ms. Hukkelhoven") ceases to be a director of the Issuer. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F3 · ownership.nature: Ms. Hukkelhoven is a Managing Director of Perceptive Advisors, LLC (the "Advisor"). The Advisor serves as the investment manager of Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). The Advisor may be deemed to have an indirect pecuniary interest in the securities reported herein because the Advisor has the right to receive the director compensation provided in respect of Ms. Hukkelhoven's board service through a partial management fee offset. Joseph Edelman ("Mr. Edelman") is the managing member of the Advisor. Each of Mr. Edelman, the Master Fund and the Advisor disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman, the Master Fund or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 11, 2026 Filed Jun 16, 2026 00:56 UTC |
Yu DebraDirector
|
GrantRestricted Share Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001869480-26-000002 · form4-06162026_120619.xml · derivative · entry 1 Yu Debra · CIK 0001869480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. Read SEC document |
| June 11, 2026 Filed Jun 16, 2026 00:54 UTC |
Mendoza NeilDirector
|
GrantRestricted Share Units · Derivative | 66,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001742502-26-000002 · form4-06162026_120625.xml · derivative · entry 1 Mendoza Neil · CIK 0001742502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,641 Underlying: Ordinary Shares · 66,641 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. Read SEC document |
| June 11, 2026 Filed Jun 16, 2026 00:55 UTC |
SHENK THOMAS EDirector
|
GrantRestricted Share Units · Derivative | 69,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001204362-26-000002 · form4-06162026_120643.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,662 Underlying: Ordinary Shares · 69,662 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. Read SEC document |
| June 11, 2026 Filed Jun 16, 2026 00:55 UTC |
Seligman NicoleDirector
|
GrantRestricted Share Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683100-26-000002 · form4-06162026_120608.xml · derivative · entry 1 Seligman Nicole · CIK 0001683100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. Read SEC document |
| June 11, 2026 Filed Jun 16, 2026 00:53 UTC |
Hukkelhoven EllenDirector
|
GrantRestricted Share Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001743337-26-000002 · form4-06162026_120653.xml · derivative · entry 1 Hukkelhoven Ellen · CIK 0001743337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. Read SEC document |
| June 11, 2026 Filed Jun 16, 2026 00:53 UTC |
Harris Keith R.Director
|
GrantRestricted Share Units · Derivative | 106,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001742703-26-000004 · form4-06162026_120624.xml · derivative · entry 1 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,441 Underlying: Ordinary Shares · 106,441 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 00:01 UTC |
Harris Keith R.Director
|
Exercise / conversionRestricted Share Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001742703-26-000002 · form4-06112026_120625.xml · derivative · entry 2 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: The restricted share units vest in a single annual installment upon the earlier of (i) June 12, 2026 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2026. F2 · derivative.expiration_date: The restricted share units vest in a single annual installment upon the earlier of (i) June 12, 2026 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2026. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 00:01 UTC |
Harris Keith R.Director
|
Exercise / conversionOrdinary Shares | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001742703-26-000002 · form4-06112026_120625.xml · nonDerivative · entry 1 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| May 27, 2026 Filed May 29, 2026 01:04 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001742734-26-000012 · form4-05292026_010506.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 964,530 Read SEC document |
| May 19, 2026 Filed May 20, 2026 01:05 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
SaleOrdinary Shares | 62,000 | $9.17 | $568,540.00 |
DisclosureSEC source: 0001678604-26-000014 · form4-05202026_010516.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,387,695 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $8.96 to $9.32, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 13, 2026 Filed May 15, 2026 01:06 UTC |
Fleck Penny ReneeCHIEF DEVELOPMENT OFFICER
|
GrantRestricted Share Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002133828-26-000004 · form4-05152026_010527.xml · derivative · entry 2 Fleck Penny Renee · CIK 0002133828 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on May 1, 2028, and twenty-five percent of the restricted share unit award will vest on each of May 1, 2029 and May 1, 2030. F3 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on May 1, 2028, and twenty-five percent of the restricted share unit award will vest on each of May 1, 2029 and May 1, 2030. Read SEC document |
| May 13, 2026 Filed May 15, 2026 01:06 UTC |
Fleck Penny ReneeCHIEF DEVELOPMENT OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.97 | $0.00 |
DisclosureSEC source: 0002133828-26-000004 · form4-05152026_010527.xml · derivative · entry 1 Fleck Penny Renee · CIK 0002133828 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires 2036-05-01 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on May 1, 2027 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 01:01 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 56,000 | $10.22 | $572,320.00 |
DisclosureSEC source: 0001742734-26-000010 · form4-04222026_010415.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 971,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $9.96 to $10.60, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2026 Filed Apr 24, 2026 00:59 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
GrantOrdinary Shares | 555,555 | $9.00 | $4,999,995.00 |
DisclosureSEC source: 0001193125-26-174407 · ownership.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 10,786,658 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 00:57 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
SaleOrdinary Shares | 27,661 | $9.36 | $258,906.96 |
DisclosureSEC source: 0001742771-26-000008 · form4-04082026_120435.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 668,505 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $9.11 to $9.52, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 25, 2026 Filed Apr 24, 2026 00:59 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
GrantWarrant (Right to Buy) · Derivative | 300,000 | Not disclosed Strike: $8.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-174407 · ownership.xml · derivative · entry 7 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 300,000 Underlying: Ordinary Shares · 300,000 shares Expires 2027-08-02 F3 · price: On March 25, 2026, the Issuer, Credit Fund III, and the other parties to the Financing Agreement entered into an agreement whereby the exercise price of the warrants was adjusted to $8.00 per share. F2 · ownership.nature: Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto. Perceptive Credit Advisors LLC ("Perceptive Credit Advisors") serves as the investment advisor to Credit Fund III and as a relying advisor under the Advisor. Mr. Edelman is the managing member of Perceptive Credit Advisors. Each of Perceptive Credit Advisors, the Advisor and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of Perceptive Credit Advisors, the Advisor and Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 25, 2026 Filed Apr 24, 2026 00:59 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
GrantWarrant (Right to Buy) · Derivative | 400,000 | Not disclosed Strike: $8.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-174407 · ownership.xml · derivative · entry 6 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 400,000 Underlying: Ordinary Shares · 400,000 shares Expires 2027-08-02 F3 · price: On March 25, 2026, the Issuer, Credit Fund III, and the other parties to the Financing Agreement entered into an agreement whereby the exercise price of the warrants was adjusted to $8.00 per share. F2 · ownership.nature: Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto. Perceptive Credit Advisors LLC ("Perceptive Credit Advisors") serves as the investment advisor to Credit Fund III and as a relying advisor under the Advisor. Mr. Edelman is the managing member of Perceptive Credit Advisors. Each of Perceptive Credit Advisors, the Advisor and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of Perceptive Credit Advisors, the Advisor and Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 25, 2026 Filed Apr 24, 2026 00:59 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
Disposition to issuerWarrant (Right to Buy) · Derivative | 300,000 | Not disclosed Strike: $20.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-174407 · ownership.xml · derivative · entry 5 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 300,000 shares Expires 2027-08-02 F3 · price: On March 25, 2026, the Issuer, Credit Fund III, and the other parties to the Financing Agreement entered into an agreement whereby the exercise price of the warrants was adjusted to $8.00 per share. F2 · ownership.nature: Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto. Perceptive Credit Advisors LLC ("Perceptive Credit Advisors") serves as the investment advisor to Credit Fund III and as a relying advisor under the Advisor. Mr. Edelman is the managing member of Perceptive Credit Advisors. Each of Perceptive Credit Advisors, the Advisor and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of Perceptive Credit Advisors, the Advisor and Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 25, 2026 Filed Apr 24, 2026 00:59 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
Disposition to issuerWarrant (Right to Buy) · Derivative | 400,000 | Not disclosed Strike: $15.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-174407 · ownership.xml · derivative · entry 4 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 400,000 shares Expires 2027-08-02 F3 · price: On March 25, 2026, the Issuer, Credit Fund III, and the other parties to the Financing Agreement entered into an agreement whereby the exercise price of the warrants was adjusted to $8.00 per share. F2 · ownership.nature: Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto. Perceptive Credit Advisors LLC ("Perceptive Credit Advisors") serves as the investment advisor to Credit Fund III and as a relying advisor under the Advisor. Mr. Edelman is the managing member of Perceptive Credit Advisors. Each of Perceptive Credit Advisors, the Advisor and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of Perceptive Credit Advisors, the Advisor and Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 24, 2026 Filed Mar 25, 2026 01:12 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
SaleOrdinary Shares | 62,000 | $7.41 | $459,420.00 |
DisclosureSEC source: 0001678604-26-000010 · form4-03252026_010336.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,449,695 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.27 to $7.56, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:24 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionRestricted Share Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001815161-26-000006 · form4-02242026_020259.xml · derivative · entry 3 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,250 Underlying: Ordinary Shares · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:24 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 5,949 | $7.45 | $44,320.05 |
DisclosureSEC source: 0001815161-26-000006 · form4-02242026_020259.xml · nonDerivative · entry 2 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,377 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:24 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionOrdinary Shares | 11,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001815161-26-000006 · form4-02242026_020259.xml · nonDerivative · entry 1 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:25 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001745347-26-000006 · form4-02242026_020202.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:25 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Tax withholdingOrdinary Shares | 2,952 | $7.45 | $21,992.40 |
DisclosureSEC source: 0001745347-26-000006 · form4-02242026_020202.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,888 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:25 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionOrdinary Shares | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745347-26-000006 · form4-02242026_020202.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:20 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001742771-26-000006 · form4-02242026_020251.xml · derivative · entry 3 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:20 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Tax withholdingOrdinary Shares | 11,750 | $7.45 | $87,537.50 |
DisclosureSEC source: 0001742771-26-000006 · form4-02242026_020251.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 696,166 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:20 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionOrdinary Shares | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001742771-26-000006 · form4-02242026_020251.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 707,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:19 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionRestricted Share Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001742734-26-000006 · form4-02242026_020249.xml · derivative · entry 5 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:19 UTC |
Giroux RichardCFO & COO
|
Tax withholdingOrdinary Shares | 31,726 | $7.45 | $236,358.70 |
DisclosureSEC source: 0001742734-26-000006 · form4-02242026_020249.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,027,530 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:19 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionOrdinary Shares | 60,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001742734-26-000006 · form4-02242026_020249.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,059,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:18 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001678604-26-000006 · form4-02242026_020210.xml · derivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Ordinary Shares · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:18 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Tax withholdingOrdinary Shares | 33,048 | $7.45 | $246,207.60 |
DisclosureSEC source: 0001678604-26-000006 · form4-02242026_020210.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,511,695 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:18 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionOrdinary Shares | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678604-26-000006 · form4-02242026_020210.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 17, 2026 Filed Jan 22, 2026 02:21 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionRestricted Share Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001815161-26-000004 · form4-01222026_020121.xml · derivative · entry 3 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on January 17, 2024. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on January 17, 2024. Read SEC document |
| January 17, 2026 Filed Jan 22, 2026 02:21 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 27,206 | $7.42 | $201,868.52 |
DisclosureSEC source: 0001815161-26-000004 · form4-01222026_020121.xml · nonDerivative · entry 2 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,076 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 17, 2026 Filed Jan 22, 2026 02:21 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionOrdinary Shares | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001815161-26-000004 · form4-01222026_020121.xml · nonDerivative · entry 1 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on January 17, 2024. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.